ATE310733T1 - Thyroid-rezeptorliganden - Google Patents
Thyroid-rezeptorligandenInfo
- Publication number
- ATE310733T1 ATE310733T1 AT01303490T AT01303490T ATE310733T1 AT E310733 T1 ATE310733 T1 AT E310733T1 AT 01303490 T AT01303490 T AT 01303490T AT 01303490 T AT01303490 T AT 01303490T AT E310733 T1 ATE310733 T1 AT E310733T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- thyroid
- receptor ligands
- thyroid receptor
- disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19904400P | 2000-04-21 | 2000-04-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE310733T1 true ATE310733T1 (de) | 2005-12-15 |
Family
ID=22735966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01303490T ATE310733T1 (de) | 2000-04-21 | 2001-04-17 | Thyroid-rezeptorliganden |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1148054B1 (de) |
JP (1) | JP2002053564A (de) |
AT (1) | ATE310733T1 (de) |
BR (1) | BR0101527A (de) |
CA (1) | CA2344574C (de) |
DE (1) | DE60115132T2 (de) |
ES (1) | ES2248242T3 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6555581B1 (en) | 2001-02-15 | 2003-04-29 | Jones Pharma, Inc. | Levothyroxine compositions and methods |
EP1297833B1 (de) | 2001-09-26 | 2005-12-21 | Pfizer Products Inc. | Indolcaroboxylsäure als Thyroidrezeptor-Liganden |
WO2003045363A2 (en) * | 2001-11-30 | 2003-06-05 | Solvay Pharmaceuticals Gmbh | Treatment of th2 dominated immunological disease states with progesterone receptor antagonists |
SI1572215T1 (sl) | 2002-12-20 | 2010-01-29 | Venue Glaxo Group Ltd Glaxo We | Benzo(d)azepinski derivati za zdravljenje nevroloĺ kih motenj |
US7521465B2 (en) | 2003-01-17 | 2009-04-21 | Bexel Pharmaceuticals, Inc. | Diphenyl ether derivatives |
US7781464B2 (en) | 2003-01-17 | 2010-08-24 | Bexel Pharmaceuticals, Inc. | Heterocyclic diphenyl ethers |
US6794401B2 (en) | 2003-01-17 | 2004-09-21 | Bexel Pharmaceuticals, Inc. | Amino acid phenoxy ethers |
US7087576B2 (en) | 2003-10-07 | 2006-08-08 | Bexel Pharmaceuticals, Inc. | Dipeptide phenyl ethers |
AU2005219518A1 (en) | 2004-02-27 | 2005-09-15 | F. Hoffmann-La Roche Ag | Indazole derivatives and pharmaceutical compositions containing them |
KR100844864B1 (ko) | 2004-02-27 | 2008-07-09 | 에프. 호프만-라 로슈 아게 | 헤테로아릴-융합 피라졸로 유도체 |
CN1926139A (zh) | 2004-02-27 | 2007-03-07 | 霍夫曼-拉罗奇有限公司 | 稠合吡唑衍生物 |
GB0406378D0 (en) * | 2004-03-22 | 2004-04-21 | Karobio Ab | Novel pharmaceutical compositions |
AU2006210954A1 (en) | 2005-01-31 | 2006-08-10 | Merck & Co., Inc. | Antidiabetic bicyclic compounds |
FR2887442A1 (fr) * | 2005-06-28 | 2006-12-29 | Oreal | Composes benzyl-1,3-thiazolidine-2,4-diones, leurs utilisations et compositions pour stimuler ou induire la pousse des fibres keratiniques et/ou freiner leur chute |
BRPI0615442A2 (pt) | 2005-08-25 | 2011-05-17 | Hoffmann La Roche | inibidores de p38 map cinase e métodos para uso dos mesmos |
WO2007042878A1 (en) * | 2005-10-07 | 2007-04-19 | Orchid Research Laboratories Limited | Novel heterocyclic analogs of biphenyl ethers |
WO2007132475A1 (en) * | 2006-05-15 | 2007-11-22 | Cadila Healthcare Limited | Selective tr-beta 1 agonist |
MX2009004619A (es) | 2006-10-31 | 2009-05-15 | Cadila Healthcare Ltd | Agonistas selectivos del receptor tiroideo (tr) beta 1. |
WO2010122980A1 (ja) | 2009-04-20 | 2010-10-28 | 田辺三菱製薬株式会社 | 新規甲状腺ホルモンβ受容体作動薬 |
CN104430309A (zh) * | 2014-11-17 | 2015-03-25 | 宁夏中远天宇科技有限公司 | 一种新型的20%浓度的***酮乳油的物理生产工艺的投料配比 |
CA3075877A1 (en) | 2017-09-14 | 2019-03-21 | Riken | Method for producing retinal tissues |
SG11202109855PA (en) | 2019-03-13 | 2021-10-28 | Sumitomo Dainippon Pharma Co Ltd | Method for evaluating quality of transplant neural retina, and transplant neural retina sheet |
US20230313133A1 (en) | 2020-09-11 | 2023-10-05 | Riken | Complex Containing Neural Retina-Containing Cell Aggregates and Matrix, and Method for Manufacturing Same |
WO2022054924A1 (ja) | 2020-09-11 | 2022-03-17 | 大日本住友製薬株式会社 | 移植用組織のための媒体 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0466579A (ja) * | 1990-07-04 | 1992-03-02 | Yamanouchi Pharmaceut Co Ltd | チアゾリジン誘導体 |
TW202445B (de) * | 1991-07-30 | 1993-03-21 | Yamanouchi Pharma Co Ltd | |
FR2680512B1 (fr) * | 1991-08-20 | 1995-01-20 | Adir | Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
NO302471B1 (no) * | 1991-12-26 | 1998-03-09 | Sankyo Co | Tiazolidinforbindelser og farmasöytisk preparat |
ZA936492B (en) * | 1992-09-10 | 1995-03-02 | Lilly Co Eli | Compounds useful as hypoglycemic agents and for treating Alzheimer's disease. |
GB9713739D0 (en) * | 1997-06-27 | 1997-09-03 | Karobio Ab | Thyroid receptor ligands |
EP1048659A4 (de) * | 1997-11-12 | 2002-11-20 | Inst Med Molecular Design Inc | Retinoid-rezeptor-antagonisten |
JP2003507473A (ja) * | 1999-07-01 | 2003-02-25 | ジェロン コーポレイション | テロメラーゼインヒビターおよびその使用の方法 |
JP2001031660A (ja) * | 1999-07-14 | 2001-02-06 | Iyaku Bunshi Sekkei Kenkyusho:Kk | 甲状腺ホルモン様作用物質 |
NZ517993A (en) * | 1999-08-31 | 2004-03-26 | Incyte San Diego Inc | Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
-
2001
- 2001-04-17 DE DE60115132T patent/DE60115132T2/de not_active Expired - Fee Related
- 2001-04-17 EP EP01303490A patent/EP1148054B1/de not_active Expired - Lifetime
- 2001-04-17 ES ES01303490T patent/ES2248242T3/es not_active Expired - Lifetime
- 2001-04-17 AT AT01303490T patent/ATE310733T1/de not_active IP Right Cessation
- 2001-04-19 JP JP2001121188A patent/JP2002053564A/ja active Pending
- 2001-04-19 CA CA002344574A patent/CA2344574C/en not_active Expired - Fee Related
- 2001-04-19 BR BR0101527-3A patent/BR0101527A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2002053564A (ja) | 2002-02-19 |
ES2248242T3 (es) | 2006-03-16 |
CA2344574C (en) | 2007-02-20 |
BR0101527A (pt) | 2001-11-20 |
EP1148054A1 (de) | 2001-10-24 |
DE60115132D1 (de) | 2005-12-29 |
DE60115132T2 (de) | 2006-07-06 |
EP1148054B1 (de) | 2005-11-23 |
CA2344574A1 (en) | 2001-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60115132D1 (de) | Thyroid-Rezeptorliganden | |
YU74102A (sh) | Malonaminske kiseline i njihovi derivati kao ligandi tireoidnog receptora | |
EP1088819A3 (de) | 6-Azauracilderivate als Liganden der Thyroidrezeptoren | |
DE60208132D1 (de) | Indolcaroboxylsäure als Thyroidrezeptor-Liganden | |
DK1033364T3 (da) | Cyanholdige oxamidsyrer og -derivater som thyroideareceptorligander | |
NO20032861L (no) | Heteroarylurea nevropeptid Y Y5-reseptorantagonister | |
WO1998047505A9 (fr) | Antagoniste de recepteur de neuropeptide y | |
BG108225A (en) | Thiohydantoins and use thereof for treating diabetes | |
DE60218721D1 (en) | Pyrimidinone als melanin concentrating hormone receptor 1 | |
CA2332066A1 (en) | Tetrazole compounds as thyroid receptor ligands | |
DE60022366D1 (de) | Kondensierte imidazolderivate und arzneimittel gegen diabetes mellitus | |
DE60236322D1 (de) | Verbindungen auf pyrimidin-basis als gsk-3-hemmer | |
WO2004099150A3 (en) | 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands | |
EP1423111A4 (de) | Fxr-nr1h4-nuklearrezeptorbindende verbindungen | |
DK1054887T3 (da) | Bicykliske pyridin- og pyrimidinderivater som neuropeptid Y-receptorantagonister | |
DE60215814D1 (de) | Vinylphenyl-derivate als glk-aktivatoren | |
MXPA04003439A (es) | Compuestos de maleimida 3,4 disustituidos como antagonistas de receptor de quimiocina cxc. | |
EA200301142A1 (ru) | Производные гетероциклилокси-, -тиокси- и -аминобензазола в качестве лигандов 5-гидрокситриптамина-6 | |
EP0893498A3 (de) | cDNS Klon die für einen humanen 7-Transmembranrezeptor kodiert | |
DE69524598T2 (de) | Kondensierte imidazolderivate, ihre herstellung und verwendung | |
NO996577L (no) | Fremgangsmåte ved fremstilling av perhydroisoindol | |
EP1253139A3 (de) | Multioligoanilinierte Fullerene | |
PT1334094E (pt) | Benzo[b]tiofenos e benzo(d)isotiazoles para diminuir o colesterol | |
DK1373218T3 (da) | Imidazolylderivater til anvendelse som histamin H3-receptorligander | |
DK1377294T3 (da) | Anvendelse af neuroaktive stoffer til behandling af Parkinson's sygdom og farmaceutisk kombination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |